Stevanato Group to Demo Robotic Inspection Unit at INTERPHEX

To present modular assembly solutions and recent after-sales expansion.

By: Kristin Brooks

Managing Editor, Contract Pharma

Stevanato Group, a global provider of drug containment, drug delivery, and diagnostic solutions will showcase manufacturing and service solutions at INTERPHEX Booth 2477.  The company will provide live demonstrations of its AI-ready Vision Robot Unit (VRU) inspection system, an autonomous module capable of automatically inspecting both cosmetic and particle properties without human intervention.
 
The VRU is a robotic, human-like inspection unit combining flexibility with automation efficiency. The VRU is ideal for a broad array of applications in the pharma development and manufacturing landscape, including biotech products such as monoclonal antibodies (mAbs), vaccines and lyophilized drugs.
 
Stevanato Group will also provide insight into its modular, scalable, flexible assembly solutions. As more customized medicines are delivered via a broader array of delivery devices, a premium is being placed on equipment versatility and modularity to adapt to wide-ranging production scenarios.
 
Here, injectables are a prime example. Although many injector types have similar components, designs vary significantly in terms of size, material, and shape. This is a major production chal-lenge, both for pharmaceutical companies and contract manufacturing organizations that cater to pharma customers around the world. Stevanato Group’s modular, “building block” approach aims to streamline production, ensuring flexibility and smooth production ramp-up.
 
Additionally, a member of Stevanato Group’s expanded after-sales service team will be on hand to discuss the global program’s latest enhancements. Effective this year, companies purchasing Stevanato Group glass converting, visual inspection, assembly and packaging equipment have a dedicated team and a single point of contact. The after-sales department relies on a network of some 60 professionals across the Americas, Europe and Asia-Pacific.
 
“We’re excited to finally have the chance to reconnect face-to-face with our pharma industry customers and colleagues at one of America’s premier pharma events,” said Alessandro Zannini, Engineering Sales Director at Stevanato Group. “To meet the evolving needs of modern pharma companies, advanced technologies must be complemented by functional production versatility and by dedicated staff who can take care of the full product life cycle. We look forward to showcasing our various solutions to these challenges at INTERPHEX NYC.”

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters